AstraZeneca agrees to supply Europe with 400 million doses of COVID-19 vaccine
AstraZeneca Plc said on Saturday it signed a contract with European governments to supply the region with its potential vaccine against the coronavirus, the British drugmaker’s latest deal to pledge its drug to help combat the pandemic.
